[Construction of a recombinant <i>Bacillus subtilis</i> strain expressing SpaA and CbpB of <i>Erysipelothrix rhusiopathiae</i> and evaluation of the strain immunogenicity in a mouse model].

To construct a recombinant <i>Bacillus subtilis</i> strain expressing SpaA and CbpB of <i>Erysipelothrix rhusiopathiae</i> for oral administration, we constructed the recombinant plasmid pDG1730-CBJA by fusion PCR and seamless cloning. The plasmid was introduced into <i>B</i>. <i>subtilis</i> KC strain by natural transformation, and the recombinant strain KC-<i>spaA</i>-<i>cbpB</i> was screened out on the plate containing spectinomycin (<i>spe</i><sup><i>r</i></sup>) and confirmed by PCR and starch degradation test. The SpaA and CbpB expressed by KC-<i>spaA</i>-<i>cbpB</i> were detected by Western blotting and indirect immunofluorescence assay, and the genetic stability of the recombinant strain in mice was determined. The plasmid pMAD-∆<i>spe</i><sup>r</sup> with knockout of <i>spe</i><sup><i>r</i></sup> was constructed and transformed into KC-<i>spaA-cbpB</i>. The <i>spe</i><sup><i>r</i></sup>-deleted mutant strain KC-<i>spaA</i>-<i>cbpB</i>: : ∆<i>spe</i><sup>r</sup> was screened and identified, and its immunogenicity in a mouse model was evaluated by oral immunization. The results showed that the recombinant strain KC-<i>spaA</i>-<i>cbpB</i> was stable in mice, expressing SpaA on the cell surface and CbpB on the spore surface. KC-<i>spaA</i>-<i>cbpB</i>: : ∆<i>spe</i><sup>r</sup> expressed SpaA and CbpB. The mice vaccinated with the spores of KC-<i>spaA</i>-<i>cbpB</i>: : ∆<i>spe</i><sup>r</sup> had higher levels of SpaA and CbpB-specific IgG in the serum that those vaccinated with the wild-type spores 42 days after vaccination by gavage (<i>P</i> < 0.01). The protective rate of mice immunized with the recombinant spores was 67.5%. The results indicated that a recombinant <i>B</i>. <i>subtilis</i> strain expressing SpaA and CbpB of <i>E</i>. <i>rhusiopathiae</i> was successfully constructed, and the recombinant strain laid a foundation for the development of oral live vector vaccines for swine erysipelas.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2024-12-25
DOI
https://doi.org/10.13345/j.cjb.240456
Primary Topic
Product Development and Customization
Type
article
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

[Construction of a recombinant Bacillus subtilis strain expressing SpaA and CbpB of Erysipelothrix rhusiopathiae and evaluation of the strain immunogenicity in a mouse model].

Hongliang Shi, Zhonglin Cheng, Jixiang Li, Hao Huang et al.
PubMed
Product Development and Customization
article

[Construction of a recombinant Bacillus subtilis strain expressing SpaA and CbpB of Erysipelothrix rhusiopathiae and evaluation of the strain immunogenicity in a mouse model].

Hongliang Shi, Zhonglin Cheng, Jixiang Li, Hao Huang, Shixun Cao, Jiye Gao
article en

Abstract

To construct a recombinant <i>Bacillus subtilis</i> strain expressing SpaA and CbpB of <i>Erysipelothrix rhusiopathiae</i> for oral administration, we constructed the recombinant plasmid pDG1730-CBJA by fusion PCR and seamless cloning. The plasmid was introduced into <i>B</i>. <i>subtilis</i> KC strain by natural transformation, and the recombinant strain KC-<i>spaA</i>-<i>cbpB</i> was screened out on the plate containing spectinomycin (<i>spe</i><sup><i>r</i></sup>) and confirmed by PCR and starch degradation test. The SpaA and CbpB expressed by KC-<i>spaA</i>-<i>cbpB</i> were detected by Western blotting and indirect immunofluorescence assay, and the genetic stability of the recombinant strain in mice was determined. The plasmid pMAD-∆<i>spe</i><sup>r</sup> with knockout of <i>spe</i><sup><i>r</i></sup> was constructed and transformed into KC-<i>spaA-cbpB</i>. The <i>spe</i><sup><i>r</i></sup>-deleted mutant strain KC-<i>spaA</i>-<i>cbpB</i>: : ∆<i>spe</i><sup>r</sup> was screened and identified, and its immunogenicity in a mouse model was evaluated by oral immunization. The results showed that the recombinant strain KC-<i>spaA</i>-<i>cbpB</i> was stable in mice, expressing SpaA on the cell surface and CbpB on the spore surface. KC-<i>spaA</i>-<i>cbpB</i>: : ∆<i>spe</i><sup>r</sup> expressed SpaA and CbpB. The mice vaccinated with the spores of KC-<i>spaA</i>-<i>cbpB</i>: : ∆<i>spe</i><sup>r</sup> had higher levels of SpaA and CbpB-specific IgG in the serum that those vaccinated with the wild-type spores 42 days after vaccination by gavage (<i>P</i> < 0.01). The protective rate of mice immunized with the recombinant spores was 67.5%. The results indicated that a recombinant <i>B</i>. <i>subtilis</i> strain expressing SpaA and CbpB of <i>E</i>. <i>rhusiopathiae</i> was successfully constructed, and the recombinant strain laid a foundation for the development of oral live vector vaccines for swine erysipelas.

PubMedVol. 40(12)
Southwest University (CN)
Product Development and Customization
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.